Endothelin-1 stimulates cardiac fibroblast proliferation through activation of protein kinase C

J Mol Cell Cardiol. 2000 Apr;32(4):565-76. doi: 10.1006/jmcc.2000.1109.

Abstract

After myocardial ischemia, circulating levels of the mitogen endothelin-1 (ET-1) increase. The effects of ET-1 on cardiac fibroblasts are poorly characterized. Therefore we examined the influence of ET-1 on cardiac fibroblast proliferation with a view to elucidating the signal transduction mechanisms underlying this effect. ET-1 (10 n m) stimulated [(3)H]thymidine incorporation and cell proliferation in cultured neonatal rat cardiac fibroblasts, consistent with its activity as a mitogen. We examined the role of protein kinase C (PKC) on this function. Inhibition of PKC activation with either chelerythrine (1 microm) or staurosporine (1 n m) attenuated ET-1-induced increases in DNA synthesis and cell number. Downregulation of PKC by chronic pretreatment with 10 n m phorbol 12-myristate 13-acetate (PMA) also prevented ET-1-induced mitogenesis. In contrast to previous reports that cardiac fibroblast proliferation stimulated by angiotensin II acts independently of PKC, the ET-1 mediated mitogenic effect requires activation of PKC in these cells. Findings in adult rat cardiac fibroblasts were identical. In addition, we noted that concurrent treatment with the pro-inflammatory cytokine interleukin 1 beta which, like ET-1, is released after myocardial ischemia, attenuated the ET-1-induced increases in DNA synthesis and cell number. This effect was not mediated through a nitric oxide synthase pathway.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Alkaloids
  • Animals
  • Benzophenanthridines
  • Cell Division
  • Cells, Cultured
  • DNA / biosynthesis
  • Endothelin-1 / metabolism*
  • Endothelin-1 / pharmacology
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • Fibroblasts / cytology*
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Interleukin-1 / metabolism
  • Interleukin-1 / pharmacology
  • Isoenzymes / metabolism
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / metabolism
  • Mitogens / metabolism
  • Mitogens / pharmacology
  • Myocardium / cytology*
  • Phenanthridines / pharmacology
  • Protein Kinase C / antagonists & inhibitors*
  • Rats
  • Rats, Sprague-Dawley
  • Staurosporine / pharmacology
  • Tetradecanoylphorbol Acetate / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology

Substances

  • Alkaloids
  • Benzophenanthridines
  • Endothelin-1
  • Enzyme Inhibitors
  • Interleukin-1
  • Isoenzymes
  • Mitogens
  • Phenanthridines
  • DNA
  • chelerythrine
  • Protein Kinase C
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • Staurosporine
  • Tetradecanoylphorbol Acetate